Abstract:Background The current vaccines for porcine reproductive and respiratory syndrome virus (PRRSV) have failed to provide broad protection against infection by various strains of PRRSV. Porcine Interleukin-4 (pIL-4) plays an important role in the regulation of the immune response and has been used previously as an immunological adjuvant. The objective of this study was to construct a recombinant PRRSV expressing pIL-4 and to evaluate the immune response of the recombinant virus in piglets. Methods The pIL-4 gene was inserted in the PRRSV (CH-1R strain) infectious clone by overlap PCR. Indirect immunofluorescence assay (IFA) and Western blotting were used to confirm the recombinant virus. The stability of the recombinant virus was assessed by DNA sequencing and IFA after 15 passages in vitro . Recombinant virus was injected into pigs and efficacy of immune protection was evaluated in comparison with the parental virus. Results The recombinant virus (CH-1R/pIL-4) was successfully rescued and shown to have similar growth kinetics as the parental virus. The recombinant virus was stable for 15 passages in cell culture. Pigs vaccinated with CH-1R/pIL-4 produced a similar humoral response to the response elicited by parental virus, but IL-4 level in the supernatant of PBMCs from pigs vaccinated with CH-1R/pIL-4 was significantly higher than the parent virus at 28 days post-immunization (DPI). Flow cytometric (FCM) analysis showed that the percentage of CD4 + CD8 + double positive T (DPT) cells in the CH-1R/pIL-4 vaccinated group was significantly higher than the parental virus at 3 and 7 Days Post-Challenge (DPC), and the IL-4 level in the blood significantly increased at 7 DPC. However, the viral load and histopathology did not show significant difference between the two groups. Conclusions A recombinant PRRSV expressing porcine IL-4 was rescued and it remained genetically stable in vitro . The recombinant virus induced higher DPT ratios and IL-4 levels in the blood after HP-PRRSV challenge compared to the parental virus in piglets. However, it did not significantly improve protection efficacy of PRRSV vaccine.

CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime/killed virus boost strategy.

Boosting PRRSV-Specific Cellular Immunity: The Immunological Profiling of an Fc-Fused Multi-CTL Epitope Vaccine in Mice

Improved Cytotoxic T Lymphocyte Responses to Vaccination with Porcine Reproductive and Respiratory Syndrome Virus in 4-1BB Transgenic Pigs.

Vaccination of Mice with ORF5 Plasmid DNA of PRRSV; Enhanced Effects by Co-Immunizing with Porcine IL-15.

Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway

Enhanced Immune Responses of Mice Inoculated Recombinant Adenoviruses Expressing GP5 by Fusion with GP3 And/or GP4 of PRRS Virus

Highly Efficient Expression of Interleukin-2 under the Control of Rabbit Beta-Globin Intron Ii Gene Enhances Protective Immune Responses of Porcine Reproductive and Respiratory Syndrome (prrs) Dna Vaccine in Pigs

Cd40 Ligand Expressed in Adenovirus Can Improve the Immunogenicity of the Gp3 and Gp5 of Porcine Reproductive and Respiratory Syndrome Virus in Swine

Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice

GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.

Toll-like Receptor Ligands Enhance the Protective Effects of Vaccination Against Porcine Reproductive and Respiratory Syndrome Virus in Swine

Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4

Broadening the Heterologous Cross-Neutralizing Antibody Inducing Ability of Porcine Reproductive and Respiratory Syndrome Virus by Breeding the GP4 or M Genes

Illumination of PRRSV Cytotoxic T Lymphocyte Epitopes by the Three-Dimensional Structure and Peptidome of Swine Lymphocyte Antigen Class I (SLA-I)

Immune Responses of Pigs Immunized with a Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Porcine GM-CSF.

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

Immunization in Pigs Vaccined with DNA Encoding PRRSV GP5

Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Enhancing immunogenicity and antiviral protection of inactivated porcine reproductive and respiratory syndrome virus vaccine in piglets

A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge

HSP70 Fused with GP3 and GP5 of Porcine Reproductive and Respiratory Syndrome Virus Enhanced the Immune Responses and Protective Efficacy Against Virulent PRRSV Challenge in Pigs.